home / stock / nktr / nktr short
Short Information | Nektar Therapeutics (NASDAQ:NKTR)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,593,815 |
Total Actual Volume | 56,583,197 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 329,691 |
Average Short Percentage | 17.21% |
Is there a NKTR Short Squeeze or Breakout about to happen?
See the NKTR Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $1.31 | $1.29 | $1.335 | $1.18 | 2,299,917 | 779,985 | 33.91% |
07-03-2024 | $1.17 | $1.3 | $1.33 | $1.17 | 1,445,714 | 213,203 | 14.75% |
07-02-2024 | $1.2 | $1.17 | $1.25 | $1.1 | 1,432,921 | 399,263 | 27.86% |
07-01-2024 | $1.25 | $1.22 | $1.31 | $1.13 | 2,353,532 | 453,792 | 19.28% |
06-28-2024 | $1.16 | $1.24 | $1.3 | $1.1203 | 25,169,074 | 794,177 | 3.16% |
06-27-2024 | $1.09 | $1.14 | $1.19 | $1.07 | 2,123,996 | 438,075 | 20.63% |
06-26-2024 | $1.05 | $1.085 | $1.12 | $1.01 | 1,708,109 | 278,903 | 16.33% |
06-25-2024 | $1.16 | $1.07 | $1.16 | $1.06 | 1,781,490 | 350,348 | 19.67% |
06-24-2024 | $1.12 | $1.17 | $1.24 | $1.09 | 2,201,087 | 508,660 | 23.11% |
06-21-2024 | $1.08 | $1.16 | $1.17 | $1.04 | 2,580,941 | 244,962 | 9.49% |
06-20-2024 | $1.14 | $1.09 | $1.19 | $1.06 | 1,274,440 | 178,189 | 13.98% |
06-18-2024 | $1.16 | $1.14 | $1.16 | $1.11 | 824,440 | 127,199 | 15.43% |
06-17-2024 | $1.18 | $1.17 | $1.19 | $1.13 | 1,392,690 | 361,764 | 25.98% |
06-14-2024 | $1.22 | $1.17 | $1.235 | $1.17 | 952,107 | 136,843 | 14.37% |
06-13-2024 | $1.32 | $1.25 | $1.32 | $1.22 | 1,119,028 | 79,407 | 7.1% |
06-12-2024 | $1.26 | $1.29 | $1.385 | $1.26 | 1,292,210 | 155,059 | 12% |
06-11-2024 | $1.23 | $1.26 | $1.27 | $1.17 | 932,488 | 115,582 | 12.4% |
06-10-2024 | $1.26 | $1.205 | $1.3 | $1.19 | 2,532,628 | 338,527 | 13.37% |
06-07-2024 | $1.36 | $1.26 | $1.3895 | $1.25 | 2,039,351 | 389,502 | 19.1% |
06-06-2024 | $1.45 | $1.39 | $1.45 | $1.33 | 1,127,034 | 250,375 | 22.22% |
News, Short Squeeze, Breakout and More Instantly...
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024 PR Newswire – NKTR-0165 Demonstrates Selective Enhancement of Treg Cell Function Through Novel Agonistic ...
Nektar Management to Present at Upcoming Investor Conferences PR Newswire SAN FRANCISCO , May 30, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: Jefferies Healthcare C...
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...